Predicted LncRNA

DataTables

LncRNA Compound Cancer P-value Effect
ENSG00000272764.1 ABT-263 (navitoclax) Cervical squamouscell carcinoma and endocervical adenocarcinoma 0.017961911 Resistant
ENSG00000272764.1 ABT-263 (navitoclax) Breast invasive carcinoma 0.035274622 Sensitive